Quetiapine and Trazodone Effects on Sleep quality and Depression Severity in Patients with depressive disorder
Phase 3
Recruiting
- Conditions
- Major depressive disorder.
- Registration Number
- IRCT20231129060218N1
- Lead Sponsor
- Yasouj University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 105
Inclusion Criteria
The patient who suffering major depressive disorder according to DSM _V criteria with minimum score 20 on the hamilton depression scale .not taking other drugs to control sleepi
Not suffering from cardiovascular disease. Kidney. Diabetes
Not taking other drugs to control
Informed constant to participate in the study
Exclusion Criteria
No depression disorder (MDD)
Suffering from cardiovascular disease
Suffering from kidney . Diabetes disease
Dissatisfaction of the patient
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Depression score in Hamilton questionnaire. Timepoint: The beginning of the study and 15 and 30 days after start of the medicine. Method of measurement: Hamilton questionnaire.
- Secondary Outcome Measures
Name Time Method Severity of depression. Timepoint: The beginning of the study and 15 and 30 days after start of the medicine. Method of measurement: Hamilton questionnaire.